Chempartner Pharmatech (300149.SZ): Net loss of 62.9065 million yuan in the first half of the year, with an expanded loss compared to the same period last year.

Gelonghui Finance · Aug 29 19:16

ChemPartner Pharmatech (300149.SZ) announced its semi-annual report for 2024 on August 29. The total operating income during the reporting period was 4.65 billion yuan, a decrease of 16.56% year-on-year; the net income attributable to the shareholders of the listed company was -62.9065 million yuan, with an expanded loss year-on-year; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was -64.0386 million yuan, with an expanded loss year-on-year; the basic earnings per share was -0.1263 yuan.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

睿智医药(300149.SZ)：上半年净亏损6290.65万元，同比亏损扩大

Chempartner Pharmatech (300149.SZ): Net loss of 62.9065 million yuan in the first half of the year, with an expanded loss compared to the same period last year.

Risk Disclaimer

Statement